Globally, cardiac resynchronization therapy was valued at $4.80 billion. We Market forecasts that the market will expand at a compound annual growth rate (CAGR) of 5.3 percent from 2022 to 2033, reaching $7.20 billion. The report presents an in-depth assessment of the ‘Cardiac Resynchronization Therapy Market’. This includes enabling technologies, key trends, market...